Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FXRS0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,500
Award facts
- Contract value 100% obligated
- $32,499.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes valued at $32,499.90. The contract, awarded on July 24, 2025, carries a firm fixed-price structure with an ultimate completion date of August 14, 2025, and was issued without a set-aside designation. This delivery order is executed under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.9 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a robust portfolio of contract awards demonstrating consistent delivery of branded and generic prescription drugs, biologics, and medical consumables to military healthcare systems nationwide. The company's specialization in distributing prescription medications and injectable biologics, including other specialty pharmaceuticals such as Nexplanon, Botox, and various oncology treatments, positions it as a reliable vendor for supporting DoD medical supply requirements. The firm fixed-price structure and compressed delivery timeline reflect the operational nature of this delivery order within the broader indefinite delivery vehicle.
Quick answers
Who was awarded contract SPE2DB25FXRS0?
SPE2DB25FXRS0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FXRS0 worth?
The government has obligated $32,500 on SPE2DB25FXRS0.
Is contract SPE2DB25FXRS0 an order under another contract?
Yes. SPE2DB25FXRS0 is a delivery order under SPE2DB24D9131, an indefinite delivery contract.
Was contract SPE2DB25FXRS0 competed?
The extent of competition for SPE2DB25FXRS0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award